Neurable

Boston, United States

Neurable is a neurotechnology company focused on developing AI tools for brain signal translation and brain-computer interface technology.

$35.0M raised

Dec 2025

Series A

Top Investors

National Science FoundationGlobal Brain CorporationFundersClubInnospark VenturesHartmann Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Neurable raised?

Neurable has raised $35.0M in total funding. The most recent round was Series A. The last funding was announced in December 2025.

Who are Neurable's investors?

Neurable's investors include National Science Foundation, Global Brain Corporation, FundersClub, Innospark Ventures, Hartmann Capital.

Where is Neurable headquartered?

Neurable is headquartered in Boston, United States.

What does Neurable do?

Neurable is a neurotechnology company focused on developing AI tools for brain signal translation and brain-computer interface technology.

What stage is Neurable at?

Neurable is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 19, 2025.

MLA

"Neurable — Funding & Investors." VCBacked, December 19, 2025, https://www.vcbacked.co/company/neurable. Accessed June 12, 2026.

APA

VCBacked. (2025). Neurable — Funding & Investors. Retrieved June 12, 2026, from https://www.vcbacked.co/company/neurable

Wikipedia (cite web)

{{cite web |title=Neurable — Funding & Investors |url=https://www.vcbacked.co/company/neurable |website=VCBacked |access-date=June 12, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 19, 2025.